H. pylori infection and atrophic gastritis diagnosis

Thursday, 01 January, 2009 | Supplied by: Alere Australia


The non-invasive GastroPanel examination diagnoses H. pylori infection as well as atrophic gastritis and its location. It also reveals if risk of gastroesophageal reflux disease is increased due to high stomach acid secretion.

The examination four biomarkers in blood: pepsinogen I and II, gastrin-17 and H. pylori antibodies. It is designed for use as a primary and follow-up examination in the diagnosis and treatment of patients with dyspepsia, H. pylori infection, atrophic gastritis and related risks. If the GastroPanel examination gives a normal result, the diagnosis is either functional dyspepsia or another disease not involving the gastric mucosa. GastroSoft interpretation software shows the test results, reference ranges and diagnosis and, when necessary, also gives recommendation on possible treatment or further testing. The GastroSoft report also indicates if there is an increased risk of gastroesophageal reflux disease.

Online: www.alere.com.au
Phone: 07 3363 7100
Related Products

Lumiprobe SynaptoProbe Red dye for visualising synaptic vesicles in living neurons

Lumiprobe's SynaptoProbe Red is an analogue of FM 4-64, a widely used red fluorescent dye for...

Parse Biosciences Evercode Low Input Fixation kits for cells and nuclei

The kits empower researchers who have a small number of starting cells or nuclei who ordinarily...

EpigenTek MethylFlash Hydroxymethylated DNA Quantification Kit (Fluorometric)

The kit is a complete set of optimised buffers and reagents to fluorometrically quantify global...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd